Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ELV
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
ELV
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

ELV Price Prediction Next Week

Based on the provided data and current market conditions, here's the analysis for ELV's price movement in the next trading week:

Technical Analysis:

  • Current price: $400.96 (as of Jan 24, 2025 close)
  • Fibonacci levels indicate key resistance at $405.46 and support at $378.82
  • RSI(14) at 62.78 shows moderate bullish momentum but not overbought
  • MACD at 2.67 suggests positive momentum

News Sentiment Analysis:

  • Recent Q4 earnings release on Jan 23, 2025 showed mixed results:

    • Operating revenue of $44.99B beat consensus of $44.83B
    • Raised quarterly dividend by 4.9% to $1.71 per share
    • Medical loss ratio slightly better than expected

  • Analyst Updates:

    • TD Cowen maintains Buy rating with $484 price target
    • Barclays raised price target to $512 from $501
    • Projecting 7-9% growth in Medicare Advantage through strong member retention

Price Prediction for Next Week: Based on technical indicators and recent news:

  • Resistance levels: $405.46 (Fibonacci R1), $413.69 (Fibonacci R2)
  • Support levels: $378.82 (Fibonacci S1), $370.59 (Fibonacci S2)

Target price range: $405-410

  • Short-term upside potential supported by:
    • Positive analyst sentiment
    • Strong Medicare Advantage growth outlook
    • Dividend increase showing financial strength
    • Technical indicators showing moderate bullish momentum

Trading Recommendation: BUY

  • Entry point: Current levels around $401
  • Initial target: $405.46 (Fibonacci R1)
  • Stop loss: $394.83 (recent low)
  • Risk/reward ratio: 1:1.5

The stock shows potential for upward movement based on positive analyst sentiment and technical indicators, though traders should monitor overall market conditions and healthcare sector performance for confirmation of the trend.

Based on the provided data and current market conditions, here's the analysis for ELV's price movement in the next trading week:

Technical Analysis:

  • Current price: $400.96 (as of Jan 24, 2025 close)
  • Fibonacci levels indicate key resistance at $405.46 and support at $378.82
  • RSI(14) at 62.78 shows moderate bullish momentum but not overbought
  • MACD at 2.67 suggests positive momentum

News Sentiment Analysis:

  • Recent Q4 earnings release on Jan 23, 2025 showed mixed results:

    • Operating revenue of $44.99B beat consensus of $44.83B
    • Raised quarterly dividend by 4.9% to $1.71 per share
    • Medical loss ratio slightly better than expected

  • Analyst Updates:

    • TD Cowen maintains Buy rating with $484 price target
    • Barclays raised price target to $512 from $501
    • Projecting 7-9% growth in Medicare Advantage through strong member retention

Price Prediction for Next Week: Based on technical indicators and recent news:

  • Resistance levels: $405.46 (Fibonacci R1), $413.69 (Fibonacci R2)
  • Support levels: $378.82 (Fibonacci S1), $370.59 (Fibonacci S2)

Target price range: $405-410

  • Short-term upside potential supported by:
    • Positive analyst sentiment
    • Strong Medicare Advantage growth outlook
    • Dividend increase showing financial strength
    • Technical indicators showing moderate bullish momentum

Trading Recommendation: BUY

  • Entry point: Current levels around $401
  • Initial target: $405.46 (Fibonacci R1)
  • Stop loss: $394.83 (recent low)
  • Risk/reward ratio: 1:1.5

The stock shows potential for upward movement based on positive analyst sentiment and technical indicators, though traders should monitor overall market conditions and healthcare sector performance for confirmation of the trend.

ELV Similar Chart Price Prediction

The price of ELV is predicted to go up 11.26%, based on the high correlation periods with MOFG. The similarity of these two price pattern on the periods is 95.95%.

stocks logo

ELV

stocks logo

MOFG

Up: 11.26%Similarity: 95.95%

ELV Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

ELV Price Forecast($)

Potential Return(%)

2025

371.560

0.000

2026

500.000

34.570

2027

350.000

-4.330

2028

520.000

39.950

2029

520.000

36.970

2030

600.000

58.040

What is ELV stock price prediction 2025 ?

ELV stock is currently priced at $371.56. Based on its strong fundamentals, strategic expansion plans, and analysts' bullish outlook, the stock is projected to reach approximately $500 by the end of 2025, representing a potential upside of 36%. This forecast is supported by anticipated revenue growth, improved EPS, and favorable valuation metrics.

What is ELV stock price prediction 2026 ?

ELV stock is predicted to reach approximately $500 by 2026, driven by expected EPS growth of 12% annually and strategic expansions in Medicare and ACA plans. Analysts maintain a bullish outlook with a price target of $504.28, reflecting confidence in its long-term fundamentals. However, challenges like rising medical costs and Medicaid membership declines could moderate gains.

What is ELV stock price prediction 2027 ?

Predicting the price of ELV stock in 2027 is challenging, but it could reach around $350 based on projected growth in the healthcare sector and the company's expanding market share. Factors such as increased demand for digital health solutions and strategic acquisitions may drive this growth. Additionally, strong financial performance and innovation in services could further enhance investor confidence, supporting the price target.

What is ELV stock price prediction 2028 ?

The price prediction for ELV stock in 2028 is approximately $520. This estimate is based on its strong fundamentals, including consistent revenue growth, strategic expansions, and a projected annual EPS growth rate of 12% from 2025 onwards. Additionally, the healthcare sector's resilience and increasing demand for services support this optimistic outlook.

What is ELV stock price prediction 2029 ?

ELV stock is projected to reach approximately $520 by 2029, driven by consistent revenue growth, strategic expansions, and a focus on vertical integration in healthcare services. The company's robust fundamentals, including a low P/E ratio and expected annual EPS growth of over 12%, support this valuation. However, risks such as rising medical costs and Medicaid challenges could moderate the pace of growth.

What is ELV stock price prediction 2030 ?

ELV's stock price prediction for 2030 is estimated to reach approximately $600-$650, driven by consistent revenue growth, strategic expansions, and a focus on healthcare innovation. This projection assumes a compound annual growth rate (CAGR) of 6-8% in earnings, aligning with historical performance and industry trends. However, risks such as regulatory changes and rising medical costs could impact this trajectory.

ELV Revenue Forecast

ELV EPS Forecast

ELV FAQs

What is revenue forecast for next quarter？

The market consensus for 's revenue in the upcoming quarter is projected to be approximately $46.335B USD.

What is eps forecast for next quarter？

The market consensus for 's eps in the upcoming quarter is projected to be approximately $10.78 USD.

ELV VS S&P500

Elevance continues to use its scale-related advantages for the benefit of clients, and we remain intrigued by its ongoing efforts to align incentives with caregivers, including the deployment of high performance provider networks.

The company's Carelon services platform, which includes its PBM, should support material savings for clients, higher profitability for Elevance, and the potential to boost growth with cross-selling opportunities.

Management aims for relatively high annualized earnings growth of 12%-15% in the long run.

Ask Intellectia about ELV

ELV Analyst's Forecast

Andrew Mok

Barclays

Buy

Price Target

$501 → $512

Upside

+27.69%

Barclays raised the firm's price target on Elevance Health to $512 from $501 and keeps an Overweight rating on the shares post the Q4 report. The firm says it still struggles to understand 2025 Medicare Advantage enrollment growth comments and looks for a negative revision in the next cut of Centers for Medicare and Medicaid Services' enrollment data.
David Macdonald

Truist Securities

Strong Buy

Price Target

$520 → $480

Upside

+26.43%

Ann Hynes

Mizuho

Buy

Price Target

$585 → $505

Upside

+20.88%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free